In a sneak peek of his panel discussion at this Thursday’s AI Deciphered summit, Merck’s digital privacy director, Nevada Heft, shares what pharma marketers need to know about the ethical challenges ...

A recent decision by USDA could pave the way for an H5N1 avian flu vaccine for dairy cows by as early as the first quarter of ...

The US Department of Agriculture (USDA) has taken a significant step towards the approval of an H5N1 avian flu vaccine for ...

The major companies operating in the global depth filtration market include Merck KGaA (Germany), Danaher Corporation (US), ...

Thank you for joining us on this week’s podcast. Be sure to join us next week. We’ll be joined by Nevada Health who’s the chief privacy officer at Merck for AI deciphered preview podcast. That’s it ...

Although Europe is home to the major vehicle chip supplier NXP Semiconductor NV, Infineon Technologies AG, industrial chemical supplier Merck AG and ASML Holding ... Gudeng, the sole supplier of ...

A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer.

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 5.6% over the past three months. But if you pay close attention, you might find that ...

In an email, the company pointed out that the majority of patients in LITESPARK-005 received Welireg as their third or fourth-line treatment (87.4%) after being treated with PD-1/L1 inhibitor and ...

Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to the first study to show such a benefit in these patients. After five ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...